The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Coagulation Factor IX Market Research Report 2024
Synopsis
Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.
The global Coagulation Factor IX market was valued at US$ 362 million in 2023 and is anticipated to reach US$ 526 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Coagulation Factor IX, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coagulation Factor IX.
Report Scope
The Coagulation Factor IX market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Coagulation Factor IX market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coagulation Factor IX manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
CSL Behring
Grifols
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo
Segment by Type
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)
Segment by Application
Adult
Kids
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Coagulation Factor IX manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Coagulation Factor IX in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.
The global Coagulation Factor IX market was valued at US$ 362 million in 2023 and is anticipated to reach US$ 526 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Coagulation Factor IX, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coagulation Factor IX.
Report Scope
The Coagulation Factor IX market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Coagulation Factor IX market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coagulation Factor IX manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
CSL Behring
Grifols
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo
Segment by Type
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)
Segment by Application
Adult
Kids
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Coagulation Factor IX manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Coagulation Factor IX in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Coagulation Factor IX Market Overview
1.1 Product Overview and Scope of Coagulation Factor IX
1.2 Coagulation Factor IX Segment by Type
1.2.1 Global Coagulation Factor IX Market Value Comparison by Type (2024-2030)
1.2.2 Coagulation Factor IX (Plasma Derived)
1.2.3 Coagulation Factor IX (Recombinant)
1.3 Coagulation Factor IX Segment by Application
1.3.1 Global Coagulation Factor IX Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Kids
1.4 Global Coagulation Factor IX Market Size Estimates and Forecasts
1.4.1 Global Coagulation Factor IX Revenue 2019-2030
1.4.2 Global Coagulation Factor IX Sales 2019-2030
1.4.3 Global Coagulation Factor IX Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Coagulation Factor IX Market Competition by Manufacturers
2.1 Global Coagulation Factor IX Sales Market Share by Manufacturers (2019-2024)
2.2 Global Coagulation Factor IX Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Coagulation Factor IX Average Price by Manufacturers (2019-2024)
2.4 Global Coagulation Factor IX Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Coagulation Factor IX, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Coagulation Factor IX, Product Type & Application
2.7 Coagulation Factor IX Market Competitive Situation and Trends
2.7.1 Coagulation Factor IX Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Coagulation Factor IX Players Market Share by Revenue
2.7.3 Global Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Coagulation Factor IX Retrospective Market Scenario by Region
3.1 Global Coagulation Factor IX Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Coagulation Factor IX Global Coagulation Factor IX Sales by Region: 2019-2030
3.2.1 Global Coagulation Factor IX Sales by Region: 2019-2024
3.2.2 Global Coagulation Factor IX Sales by Region: 2025-2030
3.3 Global Coagulation Factor IX Global Coagulation Factor IX Revenue by Region: 2019-2030
3.3.1 Global Coagulation Factor IX Revenue by Region: 2019-2024
3.3.2 Global Coagulation Factor IX Revenue by Region: 2025-2030
3.4 North America Coagulation Factor IX Market Facts & Figures by Country
3.4.1 North America Coagulation Factor IX Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Coagulation Factor IX Sales by Country (2019-2030)
3.4.3 North America Coagulation Factor IX Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Coagulation Factor IX Market Facts & Figures by Country
3.5.1 Europe Coagulation Factor IX Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Coagulation Factor IX Sales by Country (2019-2030)
3.5.3 Europe Coagulation Factor IX Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Coagulation Factor IX Market Facts & Figures by Country
3.6.1 Asia Pacific Coagulation Factor IX Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Coagulation Factor IX Sales by Country (2019-2030)
3.6.3 Asia Pacific Coagulation Factor IX Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Coagulation Factor IX Market Facts & Figures by Country
3.7.1 Latin America Coagulation Factor IX Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Coagulation Factor IX Sales by Country (2019-2030)
3.7.3 Latin America Coagulation Factor IX Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Coagulation Factor IX Market Facts & Figures by Country
3.8.1 Middle East and Africa Coagulation Factor IX Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Coagulation Factor IX Sales by Country (2019-2030)
3.8.3 Middle East and Africa Coagulation Factor IX Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coagulation Factor IX Sales by Type (2019-2030)
4.1.1 Global Coagulation Factor IX Sales by Type (2019-2024)
4.1.2 Global Coagulation Factor IX Sales by Type (2025-2030)
4.1.3 Global Coagulation Factor IX Sales Market Share by Type (2019-2030)
4.2 Global Coagulation Factor IX Revenue by Type (2019-2030)
4.2.1 Global Coagulation Factor IX Revenue by Type (2019-2024)
4.2.2 Global Coagulation Factor IX Revenue by Type (2025-2030)
4.2.3 Global Coagulation Factor IX Revenue Market Share by Type (2019-2030)
4.3 Global Coagulation Factor IX Price by Type (2019-2030)
5 Segment by Application
5.1 Global Coagulation Factor IX Sales by Application (2019-2030)
5.1.1 Global Coagulation Factor IX Sales by Application (2019-2024)
5.1.2 Global Coagulation Factor IX Sales by Application (2025-2030)
5.1.3 Global Coagulation Factor IX Sales Market Share by Application (2019-2030)
5.2 Global Coagulation Factor IX Revenue by Application (2019-2030)
5.2.1 Global Coagulation Factor IX Revenue by Application (2019-2024)
5.2.2 Global Coagulation Factor IX Revenue by Application (2025-2030)
5.2.3 Global Coagulation Factor IX Revenue Market Share by Application (2019-2030)
5.3 Global Coagulation Factor IX Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Coagulation Factor IX Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 CSL Behring
6.2.1 CSL Behring Corporation Information
6.2.2 CSL Behring Description and Business Overview
6.2.3 CSL Behring Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Behring Coagulation Factor IX Product Portfolio
6.2.5 CSL Behring Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Coagulation Factor IX Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Novo Nordisk
6.4.1 Novo Nordisk Corporation Information
6.4.2 Novo Nordisk Description and Business Overview
6.4.3 Novo Nordisk Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novo Nordisk Coagulation Factor IX Product Portfolio
6.4.5 Novo Nordisk Recent Developments/Updates
6.5 Bioverativ
6.5.1 Bioverativ Corporation Information
6.5.2 Bioverativ Description and Business Overview
6.5.3 Bioverativ Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bioverativ Coagulation Factor IX Product Portfolio
6.5.5 Bioverativ Recent Developments/Updates
6.6 Sanquin
6.6.1 Sanquin Corporation Information
6.6.2 Sanquin Description and Business Overview
6.6.3 Sanquin Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanquin Coagulation Factor IX Product Portfolio
6.6.5 Sanquin Recent Developments/Updates
6.7 Takeda
6.6.1 Takeda Corporation Information
6.6.2 Takeda Description and Business Overview
6.6.3 Takeda Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Takeda Coagulation Factor IX Product Portfolio
6.7.5 Takeda Recent Developments/Updates
6.8 Baxter
6.8.1 Baxter Corporation Information
6.8.2 Baxter Description and Business Overview
6.8.3 Baxter Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Baxter Coagulation Factor IX Product Portfolio
6.8.5 Baxter Recent Developments/Updates
6.9 Aptevo
6.9.1 Aptevo Corporation Information
6.9.2 Aptevo Description and Business Overview
6.9.3 Aptevo Coagulation Factor IX Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Aptevo Coagulation Factor IX Product Portfolio
6.9.5 Aptevo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coagulation Factor IX Industry Chain Analysis
7.2 Coagulation Factor IX Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coagulation Factor IX Production Mode & Process
7.4 Coagulation Factor IX Sales and Marketing
7.4.1 Coagulation Factor IX Sales Channels
7.4.2 Coagulation Factor IX Distributors
7.5 Coagulation Factor IX Customers
8 Coagulation Factor IX Market Dynamics
8.1 Coagulation Factor IX Industry Trends
8.2 Coagulation Factor IX Market Drivers
8.3 Coagulation Factor IX Market Challenges
8.4 Coagulation Factor IX Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
